A detailed history of Voya Investment Management LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 56,024 shares of CTLT stock, worth $3.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,024
Previous 60,037 6.68%
Holding current value
$3.42 Million
Previous $3.38 Million 0.53%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $225,370 - $244,632
-4,013 Reduced 6.68%
56,024 $3.39 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $143,487 - $152,699
2,678 Added 4.67%
60,037 $3.38 Million
Q1 2024

May 15, 2024

SELL
$42.56 - $59.82 $65,287 - $91,763
-1,534 Reduced 2.6%
57,359 $3.24 Million
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $70,409 - $101,895
-2,188 Reduced 3.58%
58,893 $2.65 Million
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $51,183 - $58,131
-1,158 Reduced 1.86%
61,081 $2.78 Million
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $3.1 Million - $6.54 Million
-97,266 Reduced 60.98%
62,239 $2.7 Million
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $6.08 Million - $9.94 Million
-133,877 Reduced 45.63%
159,505 $10.5 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $2.82 Million - $5.51 Million
68,040 Added 30.19%
293,382 $13.2 Million
Q3 2022

Mar 03, 2023

SELL
$72.36 - $113.1 $4.92 Million - $7.7 Million
-68,040 Reduced 23.19%
225,342 $16.3 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $10.7 Million - $16.7 Million
148,077 Added 191.65%
225,342 $16.3 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $60,691 - $79,378
-696 Reduced 0.89%
77,265 $8.29 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $14,316 - $18,922
152 Added 0.2%
77,961 $8.65 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $734,159 - $853,889
6,140 Added 8.57%
77,809 $9.96 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $145,414 - $189,610
-1,332 Reduced 1.82%
71,669 $9.54 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $588,995 - $679,100
5,870 Added 8.74%
73,001 $7.89 Million
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $9,744 - $12,025
-96 Reduced 0.14%
67,131 $7.07 Million
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $435,755 - $534,596
-5,074 Reduced 7.02%
67,227 $7 Million
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $2.41 Million - $3.06 Million
33,098 Added 84.43%
72,301 $6.19 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $6.74 Million - $11.1 Million
-140,285 Reduced 78.16%
39,203 $2.87 Million
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $5.13 Million - $8.74 Million
138,885 Added 342.06%
179,488 $9.32 Million
Q4 2019

Feb 14, 2020

SELL
$47.06 - $56.64 $29,741 - $35,796
-632 Reduced 1.53%
40,603 $2.29 Million
Q3 2019

Nov 14, 2019

SELL
$47.45 - $58.05 $26,572 - $32,508
-560 Reduced 1.34%
41,235 $1.97 Million
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $246,670 - $340,601
-6,283 Reduced 13.07%
41,795 $2.27 Million
Q1 2019

May 15, 2019

SELL
$29.84 - $43.92 $13.8 Million - $20.3 Million
-462,581 Reduced 90.59%
48,078 $1.95 Million
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $7.99 Million - $12.4 Million
-266,867 Reduced 34.32%
510,659 $15.9 Million
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $1.86 Million - $2.11 Million
-46,250 Reduced 5.61%
777,526 $35.4 Million
Q2 2018

Aug 14, 2018

SELL
$38.72 - $42.52 $18.5 Million - $20.3 Million
-478,364 Reduced 36.74%
823,776 $34.5 Million
Q1 2018

May 15, 2018

BUY
$39.4 - $47.39 $8.17 Million - $9.83 Million
207,381 Added 18.94%
1,302,140 $53.5 Million
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $8.21 Million - $9.47 Million
220,183 Added 25.18%
1,094,759 $45 Million
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $29.5 Million - $36.4 Million
874,576
874,576 $34.9 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.